A company that profits from the sale of tobacco products that cause COPD should not profit from the sale of products that treat COPD Washington, D.C., July 29, 2021 – Philip Morris International, which markets cigarettes internationally, is purchasing the...
June 9, 2021- FOR IMMEDIATE RELEASE The 2021 Virtual Alpha-1 National Conference will take place from June 10th- June 12th, 2021 bringing the Alpha-1 Community together for three days of education, information, key opinion leader presentations and networking in a...
“Joe Zuraw has been a friend to the Alpha-1 Community for more than 20 years, he has worked tirelessly on behalf of patients his entire career. This honor could not be a better tribute to both Joe and also towards the John W. Walsh Translational Research Award....
FOR IMMEDIATE RELEASE November 2, 2020- The Alpha-1 Foundation is proud to announce the establishment of the Alpha-1 Foundation Therapeutic Development Network (TDN). The Alpha-1 TDN is a collaborative group comprised of the top specialists, researchers and our...
Miami, October 30, 2020 – Each year, the Alpha-1 Foundation recognizes November as Alpha-1 Awareness Month in order to raise awareness for Alpha-1 Antitrypsin Deficiency (Alpha-1) around the United States. This special month is commemorated by the wide variety of...
August 18, 2020 The National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) has announced the award of a large rare disease grant which will focus on Alpha-1 Antitrypsin Deficiency. The grant entitled Alpha-1 Antitrypsin Disease Cohort:...
